UBS O'Connor’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

UBS O'Connor’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,850,120	Closed	-$230M	–	702
2023 Q2	$230M	Buy	+5,850,120	New	+$206M	4.85%	4
2022 Q3	–	Sell	-109,750	Closed	-$1.06M	–	1029
2022 Q2	$1.06M	Buy	+109,750	New	+$1.38M	0.01%	753
2016 Q3	–	Sell	-20,000	Closed	-$1.02M	–	516
2016 Q2	$1.02M	Buy	20,000 +834	+4%	+$41.4K	0.02%	301
2016 Q1	$811K	Buy	+19,166	New	+$977K	0.01%	372

UBS O'Connor's ISEE Position: Q3 2023 in Review

UBS O'Connor sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 5,850,120 shares — an estimated $230M sold.

UBS O'Connor first reported a position in ISEE in Q1 2016 and held it in 4 quarters. The position peaked at $230M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

UBS O'Connor reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
UBS O'Connor sold 5,850,120 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $230M.
UBS O'Connor first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 4 quarters.
UBS O'Connor's IVERIC bio, Inc. Common Stock position peaked at $230M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.